Laboratory Products
Genetically Characterised FFPE Tissue Samples
Mar 14 2014
Amsbio has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples.
CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation Sequencing using Illumina’s TruSeq Amplicon - Cancer Panel (TSACP). Available as tissue slides and whole blocks, samples are delivered with the mutation and variation data for 48 cancer-related genes including BRAF, KRAS, EGFR, ALK and TP53.
CancerSeq™ tissue samples provide researchers with the perfect medium for applications including validation of cancer marker mutation related drug candidates; companion diagnostic assay development; cellular localisation of tissue specific mRNA and protein expression; Comparison of the locations of novel genes in different tissues as well as in situ hybridisation, immunohistochemistry, and in situ PCR experiments.
Available from several tumour tissue types, donor clinical history data is provided with each CancerSeq™ sample. In addition, Amsbio offers custom services to characterise your specimens or selected samples from its biorepository of cancer and normal FFPE blocks.
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Oct 06 2024 Liverpool, UK
Oct 08 2024 Gothenburg, Sweden
Oct 09 2024 Birmingham, UK
Oct 09 2024 NEC, Birmingham, UK
Oct 15 2024 Milan, Italy